Kavas Maneck Chemicals Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 0.75 M
as on 21-06-2024
- Paid Up Capital ₹ 0.60 M
as on 21-06-2024
- Company Age 48 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 3.90 M
as on 21-06-2024
- Revenue %
(FY 2020)
- Profit -3.17%
(FY 2020)
- Ebitda 48.85%
(FY 2020)
- Net Worth -0.34%
(FY 2020)
- Total Assets 0.21%
(FY 2020)
About Kavas Maneck Chemicals
The Company is engaged in the Chemicals And Resources Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.75 M and a paid-up capital of Rs 0.60 M.
The company has closed loans amounting to ₹3.90 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Darius Kavasmaneck and Aban Kavasmaneck serve as directors at the Company.
- CIN/LLPIN
U24110MH1976PTC018916
- Company No.
018916
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Mar 1976
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Kavas Maneck Chemicals?
Executive Team (1)
DK
Darius Kavasmaneck
Managing DirectorAppointment Date: 24-Mar-1976
Status: Current
Board Members(1)
Financial Performance and Corporate Structure Insights of Kavas Maneck Chemicals.
Kavas Maneck Chemicals Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 3.17% decrease in profit. The company's net worth dipped by a decrease of 0.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kavas Maneck Chemicals?
In 2019, Kavas Maneck Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Western International Private Limited
Active
18 years 4 months Darius Kavasmaneck and Aban Kavasmaneck are mutual person
Western Chemical Industries Private Limited
Active 23 years 3 months Darius Kavasmaneck and Aban Kavasmaneck are mutual person
Kavasmaneck Dyestuffs Private Limited
Active 44 years 9 months Darius Kavasmaneck and Aban Kavasmaneck are mutual person
Western Organic Chemical Industries Private Limited
Active 21 years Darius Kavasmaneck and Aban Kavasmaneck are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 05 Jul 1982 | ₹0.40 M | Satisfied |
Canara Bank Creation Date: 06 Nov 1978 | ₹3.50 M | Satisfied |
How Many Employees Work at Kavas Maneck Chemicals?
Unlock and access historical data on people associated with Kavas Maneck Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
As of Apr 10, 2017, Kavas Maneck Chemicals has raised a total of ₹ 0.2 M, with the most recent deal valued at ₹ 0.1 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
